Zerlasiran sodium
Zerlasiran sodium, an apolipoprotein A (ApoA) synthesis reducer, is a small interfering RNA (siRNA) therapeutic developed for the treatment of cardiovascular diseases. By specifically targeting and silencing the messenger RNA (mRNA) responsible for the production of atherogenic proteins, zerlasiran aims to reduce the expression of these proteins and thereby mitigate the progression of atherosclerosis and other related conditions.
* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.
Synonyms
SLN360 sodium; RNA, (Am-sp-(2'-deoxy-2'-fluoro)U-sp-Am-(2'-deoxy-2'-fluoro)A-Cm-(2'-deoxy-2'-fluoro)U-Cm-(2'-deoxy-2'-fluoro)U-Gm-(2'-deoxy-2'-fluoro)U-Cm-(2'-deoxy-2'-fluoro)C-Am-(2'-deoxy-2'-fluoro)U-Um-(2'-deoxy-2'-fluoro)A-Cm-sp-(2'-deoxy-2'-fluoro)C-sp-Gm), complex with RNA (Cm-Gm-Gm-Um-Am-Am-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)G-(2'-deoxy-2'-fluoro)G-Am-Cm-Am-Gm-Am-Gm-Um-Um-sp-Am-sp-Um) 5'-[O-[21-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-9,9-bis[12-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-7-mercapto-7-oxido-2,6,8-trioxa-7-phosphadodec-1-yl]-16-mercapto-16-oxido-7,11,15,17-tetraoxa-16-phosphaheneicos-1-yl] hydroxy phosphate] (1:1), sodium salt
Molecular Weight
14155.81
Molecular Formula
C443H556F12N144Na38O277P40S10
Solubility
Soluble in DMSO.
Appearance
White to off-white solid
Chemical Structure:

Our Products
BOC Sciences is a leading provider of DNA and RNA products and services that meet the needs of
researchers and pharmaceutical companies worldwide. Its broad product portfolio includes various types of
oligonucleotides, DNA/RNA synthesis feedstocks, RNA interference tools, and advanced drug delivery systems, among
others. Designed to promote cutting-edge research and innovative therapeutic solutions, at BOC Sciences you are sure
to find the right product for you.